Back
Windtree Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
15
WINT
Windtree Therapeutics
Last Price:
0.35
Seasonality Move:
-8.96%
Buy
79
PLX
Protalix BioTherapeutics
Last Price:
1.79
Seasonality Move:
86.79%
Sell
15
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy, Sell or Hold?
- The current Windtree Therapeutics [WINT] share price is $0.37. The Score for WINT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- WINT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
79
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.83. The Score for PLX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WINT Stock Price Chart
What is Windtree Therapeutics's stock price today?
-
The Windtree Therapeutics share price today is $0.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing slight buying pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
WINT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 27.48 | Sell |
| Chaikin Money Flow: | 10375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.6) | Sell |
| Bollinger Bands (100): | (-0.2 - 7.72) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 74.3 | Buy |
| Chaikin Money Flow: | 637953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.33 - 1.75) | Buy |
| Bollinger Bands (100): | (0.93 - 1.41) | Buy |
WINT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.44 | Sell |
| 20-day SMA: | 0.49 | Sell |
| 50-day SMA: | 0.75 | Sell |
| 200-day SMA: | 4.38 | Sell |
| 8-day EMA: | 0.43 | Sell |
| 20-day EMA: | 0.53 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 9.6 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.7 | Buy |
| 20-day SMA: | 1.62 | Buy |
| 50-day SMA: | 1.31 | Buy |
| 200-day SMA: | 1.2 | Buy |
| 8-day EMA: | 1.71 | Buy |
| 20-day EMA: | 1.6 | Buy |
| 50-day EMA: | 1.4 | Buy |
| 200-day EMA: | 1.28 | Buy |
Windtree Therapeutics Earnings Growth & WINT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $89.20 per share, and an increase next year of $2.80 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Windtree Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||